当前位置：
X-MOL 学术
›
Acta Pharm. Sin. B
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Author correction to “Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics” [Acta Pharm Sin B (2022) 4458–4471]
Acta Pharmaceutica Sinica B ( IF 14.5 ) Pub Date : 2024-02-29 , DOI: 10.1016/j.apsb.2024.02.021 Qiang Niu , Yu Liu , Yujing Zheng , Ziwei Tang , Yuna Qian , Ruogu Qi , Jianliang Shen , Ping Zhao
中文翻译：
作者对“使用六组氨酸金属纳米载体共同递送尼日利亚星和地西他滨用于细胞焦亡诱导的免疫治疗”的更正 [Acta Pharm Sin B (2022) 4458–4471]
更新日期：2024-02-29
Acta Pharmaceutica Sinica B ( IF 14.5 ) Pub Date : 2024-02-29 , DOI: 10.1016/j.apsb.2024.02.021 Qiang Niu , Yu Liu , Yujing Zheng , Ziwei Tang , Yuna Qian , Ruogu Qi , Jianliang Shen , Ping Zhao
中文翻译：
作者对“使用六组氨酸金属纳米载体共同递送尼日利亚星和地西他滨用于细胞焦亡诱导的免疫治疗”的更正 [Acta Pharm Sin B (2022) 4458–4471]
京公网安备 11010802027423号